Daniel Tardiff
Plus aucun poste en cours
Profil
Daniel Tardiff worked as a Research Head at Yumanity Therapeutics, Inc. before obtaining a doctorate degree from Brandeis University and an undergraduate degree from Stonehill College, Inc.
Anciens postes connus de Daniel Tardiff
| Sociétés | Poste | Fin |
|---|---|---|
| YUMANITY THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Formation de Daniel Tardiff
| Brandeis University | Doctorate Degree |
| Stonehill College, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
